Boehringer Ingelheim’s Spevigo (spesolimab) has been recommended by the National Institute for Health and Care Excellence ...

Ventyx Biosciences has shared promising top-line results from a phase 2a study of its investigational central nervous system ...

While AI’s influence is growing across drug discovery, clinical trials and supply chains, it doesn’t provide that ...

As Danny says: “SciLife research forecasts that AI applications could generate between $350bn and $410bn in annual value for ...

Imagine MedEd that thinks, adapts, and delivers unprecedented insights. Better yet, experience if for yourself in our ...

The use of AI in pharma can expedite drug development and manufacturing, enabling novel medicines to get to underserved ...

Galderma’s Nemluvio (nemolizumab) has demonstrated sustained and clinically meaningful improvements in the key signs and ...

Gilead Sciences’ twice-yearly injectable pre-exposure prophylaxis (PrEP) drug has been approved by the US Food and Drug ...

The US Food and Drug Administration (FDA) has approved CSL’s Andembry (garadacimab-gxii) to prevent attacks of hereditary ...

That’s why empowering local voices within global teams is mission critical. It’s not just about having someone in the seat; ...

Eli Lilly has announced that it will be acquiring Verve Therapeutics in a deal worth approximately $1.3bn, marking a ...

For years, women have been significantly underrepresented in clinical trials, despite making up a large portion of patients ...